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Abstract 
Triclosan (TCS), an antibacterial agent widely found in household and clinical 
products, is readily absorbed into human skin, but TCS effects on mammalian cells are 
largely unknown.  TCS has been found to alleviate symptoms of human eczema, via an 
unknown mechanism.  Mast cells are ubiquitous, key players in allergy, infectious 
disease, carcinogenesis, autism, and many other diseases and physiological functions.  
One important function of mast cells is release of pro-inflammatory mediators from 
intracellular granules (degranulation) upon challenge with antigen. Non-cytotoxic doses 
of TCS inhibit several functions of both human (HMC-1.2) and rat (RBL-2H3) mast 
cells, including degranulation.  Previous work in the Gosse laboratory has shown that 
TCS disrupts ATP production without cytotoxicity in RBL-2H3 and HMC-1.2 mast cells 
in glucose-free, galactose-containing media.  In the same glucose-free conditions, 15 µM 
TCS dampens RBL-2H3 degranulation by 40%. Thus, TCS affects degranulation and 
ATP production in mast cells. TCS-methyl, unlike TCS, was shown to inhibit neither of 
these processes, suggesting that TCS disrupts cellular energy production in part due to its 
ionizable proton.  Well studied mitochondrial uncouplers [e.g., carbonyl cyanide 3-
chlorophenylhydrazone (CCCP)] have been shown to disrupt mast cell function.   
Oxygen consumption rate (OCR) is a parameter that has been used to study 
mitochondrial function, since most cellular oxygen consumption is via mitochondria. 
Triclosan at 10 µM was shown to increase the cellular oxygen consumption rate in RBL-
2H3 cells, demonstrating a similar effect as 1 µM CCCP. Taken together, our data 
indicate that TCS is a mitochondrial uncoupler which disrupts mast cell signaling.  This 
mechanism could underlie TCS toxicity in numerous mammalian cell types.
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1 Introduction 
1.1 Triclosan 
 Triclosan [5-chloro-2-(2,4-dichlorophenoxy) phenol] has been used for decades as 
an antibacterial and antifungal agent1.  Originally developed as a pesticide in Switzerland, 
triclosan (TCS) was used primarily as an antiseptic agent in surgical scrubs in the 1970’s 
and 1980’s2.  Since then, TCS has been commonly found in household and clinical 
products such as toothpastes, toys, deodorants, and antiseptic soaps at concentrations 
around 10 mM3,4.  Many consumer products containing TCS are disposed into residential 
drains, leading to detectable levels in terrestrial and aquatic environments, in wild 
animals, and in humans.  According to a 1999-2000 study done in the United States, it 
was found that 75.7% of all commercially available liquid hand soaps and 26.4% of bar 
soaps contain TCS5.  TCS is readily absorbed into human skin6-9.  The widespread use of 
TCS has significance at both an environmental and organismal or cellular level.  Though 
TCS exposure is widespread, mammalian toxicology and pharmacology remain largely 
unknown.    
Triclosan works as an effective antimicrobial by blocking fatty-acid biosynthesis, 
permeabilizing the bacterial envelope10.  Studies examining lipid synthesis in E. coli have 
shown that TCS mimics the natural substrate of enoyl-acyl carrier protein reductase 
(FabI)11.  TCS is a chlorinated, aromatic chemical with an ortho positioned hydroxyl 
group on one of its phenol rings (Figure 1A).  Within the active site of FabI, the phenolic 
hydroxyl group of TCS binds to a hydroxyl group of the nicotinamide ring of the NAD+ 
cofactor and also to the phenolic oxygen of tyrosine 156, forming a noncovalent, bi-
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substrate FabI-NAD+-triclosan complex1,10.  Effectiveness of TCS as a surgical scrub 
ingredient in clinical healthcare settings has been proven1,12.   
Due to its widespread use, there has been concern that resistance may develop to 
TCS, compromising its usefulness10,13.  Recent studies have shown that the ability of 
organisms such as E. coli to acquire genetic mutations in the fabI gene or the presence of 
multidrug efflux pumps can bring rise to resistant organisms.  In E. coli, a missense 
mutation in the fabI gene to fabI[g93v] interferes with TCS’s ability to form a stable  
FabI-NAD+-triclosan complex10.  TCS has been used to manage infectious disease 
outbreaks in clinical settings such as controlling a methicillin-resistant Staphylococcus 
aureus (MRSA) outbreak in a neonatal nursery14, but has also been the cause of hospital 
outbreaks when bacteria persisted in a TCS-containing soap dispenser15.  In a 2007 
Pseudomonas aeruginosa outbreak in an Italian hematology unit, a P. aeruginosa strain 
was isolated from a heavily contaminated TCS soap dispenser.  P. aeruginosa is 
intrinsically resistant to TCS due to various resistance mechanisms16.  In the hand soap 
outbreak, TCS exposure doubled the minimum inhibitory concentration (MIC) to 
antibiotics such as ciprofloxacin, levofloxacin, tetracycline, and chloramphenicol13,15.  In 
addition, it has been demonstrated that TCS exposure to P. aeruginosa can efficiently 
select for multidrug resistant derivatives, including resistance to antipseudomonas 
drugs17.   Interestingly, TCS derivatives are being explored for use in treating 
Mycobacterium tuberculosis18.  Although a link between TCS resistance and antibiotic 
resistance has been consistently demonstrated in clinical and laboratory settings, research 
conducted at the population level has contrastingly shown little evidence of cross-
resistance to antibiotics associated with consumer use of TCS-containing products9.   
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U.S. regulatory agencies such as the Food and Drug Administration (FDA) and 
the Environmental Protection Agency (EPA) have debated issuing a ruling on the 
regulation of TCS use in consumer products, while various other nations have declared 
TCS an environmental toxicant.  TCS’s stability at temperatures up to 200°C and its high 
solubility in organic solvents contribute to its detection in the environment, in food, and 
in humans2,19-21.  TCS has been studied widely with respect to its effects in the 
environment, such as ecological toxicity in aquatic and terrestrial environments22, but 
effects of TCS in mammals are not well known.   
TCS is an ionizable compound and has a pKa of approximately 7.9.  At greater 
pH, TCS is ionized and exists in its anionic (phenolate) form.  In its anionic, phenolate 
form, TCS is susceptible to photolysis, resulting in the potential production of dioxins 
when exposed to excessive heat or prolonged sunlight in the environment23.  
Additionally, it is thought that only the neutral phenolic form of TCS is toxic to aquatic 
organisms 24 as ionized, charged molecules are less likely to cross hydrophobic lipid 
membranes. TCS likely crosses plasma membranes hydrophobically. 
1.1.1 Triclosan Methyl 
  Triclosan extensively contaminates wastewater at concentrations around 3.45 nM  
to 34.5 nM25,26, and about 90 % of TCS is removed via biodegradation25,27.  
Approximately five percent of TCS is biomethylated into triclosan-methyl (2,4,4′-
trichloro-2′-methoxy-diphenylether) under aerobic conditions27,28, retaining the same 
structure as TCS with the exception of a methyl group in place of TCS’s ionizable 
hydrogen.  The chemical structures of triclosan and triclosan-methyl (mTCS) are shown 
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in Figure 1 for comparison.  Triclosan-methyl is known to bioaccumulate more readily 
than TCS, has greater lipophilicity, and has less sensitivity toward photodegradation in 
the environment29.  Because the hydroxyl group of TCS is largely responsible for its 
antimicrobial function, mTCS, with a methyl group in place of a hydroxyl group, loses 
the antibacterial properties of its parent compound.  We hypothesize that triclosan’s 
ability to disrupt mast cell function is due, in part, to its ionizable proton.  Based on its 
structural properties, we suggest that mTCS can be used as a control to test this 
hypothesis.  
  
  
 
 
 
 
1.2 Triclosan and Human Health 
 An increasing number of studies report that triclosan affects many specific 
biological functions in various species, including humans.  TCS has low water solubility 
(up to 40 µM30 and unless at alkaline pH31) and is known to be readily absorbed in 
humans by the gastrointestinal tract8.  Additionally, due to its lipophilic properties, TCS 
has been seen to accumulate in adipose tissue and also in breast milk, amniotic fluid, 
blood, and urine32.  Testing urine is a useful biomonitoring tool for assessing information 
A) B) 
Figure 1: Structures of triclosan and methyl-triclosan 
Triclosan (5-chloro-2-(2,4-dichlorophenoxy) phenol) structure (A) and TCS-methyl 
(B) Source: PubChem 
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on baseline levels of TCS in human subjects.  A single oral dose of TCS can be detected 
in human urine samples for up to 8 days8.  In the 2003-2004 National Health and 
Nutrition Examination Survey (NHANES), it was reported that 75% of urine samples 
contained TCS, suggesting that hundreds of millions of U.S. citizens are exposed to 
TCS33.   
In clinical studies, TCS has been shown to suppress human skin atopic disease34 
through an unknown mechanism35.  Antiseptics, such as triclosan, are an alternative to 
topical antibiotics in patients suffering from atopic dermatitis36.  One randomized, 
double-blind study examining the efficacy of 1% TCS-containing emollient in 60 patients 
with atopic dermatitis reported reduced severity of the skin condition after 14 days34.  
Improvement in severity was followed by reduction in topical steroid application by 
treated patients, as well as reduction in Staphylococcus aureus colonization.  
Studies have also evaluated the biological activities of TCS in mammals and its 
potential adverse effects37.  TCS has cytotoxic effects on breast cancer cells38. 
 Additionally, upon absorption, TCS is rapidly distributed throughout the human body 
and disrupts endocrine function39, initiates anti-inflammatory responses 40,41, and affects 
the function of natural killer (NK) cells of the immune system42.  Various studies report 
chemicals in the environment which mimic natural estrogen and affect ER function in 
cells.  Such chemicals disrupt normal endocrine function and raise reproductive health 
concerns.  Studies have proposed that androgenic endocrine disrupting chemicals (EDCs) 
may reduce sperm production, alter gonad development, and contribute to neurological 
diseases in males43-45.  In vitro studies in human recombinant cells and in vivo studies in 
aquatic species have suggested that TCS has endocrine disrupting properties and may be 
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weakly androgenic46.  In rats, TCS has been shown to disrupt thyroid hormone 
homeostasis47 and also inhibit enzymatic activity of sulfotransferase and a 
glucoronosyltransferase in human liver fractions48.   
TCS has been shown to modulate anti-inflammatory effects on various immune 
cell types, including monocytes, lymphocytes, and neutrophils49.  In vitro studies have 
shown that TCS inhibits cyclo-oxygenase and lipoxygenase pathways in human gingival 
fibroblasts, decreasing TLR-induced secretion of inflammatory factors such as 
prostaglandin E2, leukotriene, and interferon-γ49,50.  While TCS has been shown to 
modulate inflammation both in vitro and in vivo, little has been elucidated about its 
mechanisms of action.  A study by Udoji et al has indicated that TCS decreases the 
target-cell destroying (lytic) function of NK cells, similar to carbamate pesticides51 and 
brominated flame-retardants52.  Human NK cells are a first line of defense protecting 
against viral infections and the development of cancers53.  TCS (10 μM) was shown to 
inhibit more than 90% of NK function within an hour of exposure and increased upon 
length of exposure54.  
Previous studies support that the pleiotropic effects of TCS indicate that various 
molecular mechanisms of action are responsible for the diverse biological effects seen in 
humans.  In eukaryotes, TCS effects have been linked to membrane interaction55.  
Membranotropic effects which impair metabolic function in isolated rat liver 
mitochondria exposed to TCS have been examined56.  In this thesis, we will explore a 
potential mechanism of action for TCS disruption of metabolic function which may 
underlie TCS effects on various biological processes. 
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1.3 Mast Cells 
The Gosse Laboratory has discovered that TCS inhibits mast cell function in 
vitro57,58.  Mast cells are highly granulated immune effector cells that play a role in Type 
I hypersensitivity and modulate allergic immune response by releasing pro-inflammatory 
mediators from intracellular granules. Mature mast cells are found in most body tissues 
and are key players in not only allergy, but also infectious disease, carcinogenesis, and 
even a host of neurological functions and diseases such as autism53,59,60.  There is recent, 
widespread evidence that mast cells also modulate behavior61.  Because mast cells are 
most abundant at host-environment interfaces such as mucosal tissues and the skin, they 
are likely exposed to TCS via use of TCS-containing consumer products.  The ubiquitous 
presence of mast cells in mammals makes them an appropriate model for examining TCS 
exposure and its effects. 
Mast cells are hematopoietic cells that develop from CD34+ /CD117+/CD13+ 
pluripotent precursor cells, originating in the bone marrow in humans 62.  In rodents, 
these progenitor cells express Thy-1lo c-kithi.  Similar to macrophages, mast cells 
circulate in the bloodstream before they migrate to the peripheral connective or mucosal 
tissues where they complete their development.  Following stem cell factor (SCF)-
induced KIT dimerization and auto-phosphorylation, KIT is activated, allowing for mast 
cell maturation.  Substantially reduced mast cell numbers have been shown in mice 
defective of KIT catalytic activity.  SCF regulates mast cell survival and elicits cell-cell 
or cell-substrate adhesion, and also facilitates proliferation, differentiation and 
development of mast cells63. 
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Mast cells are a key component of innate and adaptive immunity.  Due to their 
anatomical locations, mast cells serve as a first line of defense against pathogens such as 
bacteria, viruses, and parasites.  The hallmark characteristic of mast cell morphology is 
the presence of electron-dense, cytoplasmic granules, the basis of their discovery in the 
late nineteenth century.  The secretory granules of mast cells are composed of preformed 
chemical mediators including histamine, tryptase, serotonin, and chymase64.  Among the 
bioactive amines present in mast cell granules, histamine is the most clinically 
significant65.  In addition to preformed constituents, upon activation, de novo synthesis of 
lipid mediators such as leukotrienes and prostaglandins, cytokines, and chemokines are 
induced66.  These mediators influence a variety of cellular responses, including induction 
of inflammatory response, angiogenesis, tumorigenesis and cellular hyperplasia.  Though 
granule composition may seem homogenous, there is widespread evidence that granule 
morphology and contents are heterogeneous, as in a subdivision of granules seen in bone 
marrow-derived mast cells of mice67.  Though mast cell degranulation most notably 
occurs in response to IgE receptor cross-linking, degranulation can occur in response to 
complement activation, toxins, and neuropeptides.  The release of particular mediators 
from intracellular granules is dependent upon the tissue microenvironment68, and many of 
the physiological functions of mast cells are associated with the bioactivity of the granule 
components.  
Similar to other leukocytes, mast cells detect their external environment by virtue 
of a multiplicity of cell-surface receptors, including Fcε, Fcγ, TLRs, major 
histocompatibility complexes (MHC) classes I and II, KIT, and various interleukins69.  
Allergen-induced mast cell signaling in Type I allergic reactions occurs through 
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aggregation of the membrane embedded FcεRI receptor via antigen cross-linking of IgE 
to FcεRI on the mast cell and basophil cell surface.  The extensively studied rat 
basophilic leukemia (RBL-2H3) mast cell model, has been used to examine IgE mediated 
degranulation as well as degranulation by methods which mobilize calcium53,70. 
 
1.3.1 RBL-2H3 and HMC-1.2 Cell Lines 
Functionally homologous to human mast cells, rat basophilic leukemia cells, 
clone 2H3 (RBL-2H3)71,72 have the core functional signaling machinery of mature human 
mast cells73,74 and have been used to study mast cell signaling for decades.  RBL mast 
cells have been used as a biosensor for screening chemicals for environmental toxicity75. 
The RBL-2H3 cell line is a continuous cell line that was cloned from isolated rat 
leukemia cells treated with β-chlorethylamine, a chemical carcinogen.  RBL-2H3 cells 
have been used extensively for the study of IgE- FcεRI interactions and degranulation 
signaling pathways76 which are similar to the process seen in human basophils73,74. The 
FcεRI receptor can selectively bind murine IgE antibody and can be stimulated by 
allergen cross-linking to induce the release of granules.   
A substantial number of monoclonal cells can be obtained via basic cell culture 
technique, therefore, RBL-2H3 cells are a useful model for in vitro work and will be 
utilized in this study.  RBL-2H3 cells are a reliable model for the study of IgE-mediated 
degranulation of secretory cells containing chemical mediators such as histamine, β-
hexosaminidase, and serotonin.  To increasing concentrations of DNP-BSA antigen, 
 
 
10 
 
RBL-2H3 cells exhibit a dose response curve77.  This phenomenon in mast cells has also 
been previously reported in basophils.  
The Gosse lab has shown that non-cytotoxic, low micromolar doses of TCS 
inhibit degranulation57 and suppress ATP production in RBL cells as well as in human 
mast cells (Weatherly, Shim, Hashmi, Kennedy, Hess and Gosse, submitted).  HMC-1 
human mast cells, which lack functional FcεRI receptors 78 are immature mast cells and 
are poorly granulated 79.  The human mast cell-1.2 (HMC-1.2) model can be activated by 
calcium ionophore80.  A decrease in antigen (Ag) stimulated degranulation has been seen 
in RBL-2H3 cells exposed to carbonyl cyanide 3-chlorophenylhydrazone (CCCP), a 
potent mitochondrial uncoupler81.  In this study, we will further examine another key test 
for mitochondrial uncoupling, namely, identifying a change in oxygen consumption, in 
the RBL-2H3 cell model as it is exposed to TCS.    
 
1.4 Mast Cell Degranulation 
As previously mentioned, an important physiological function of mast cells is the 
modulation of the allergic immune response by releasing pro-inflammatory mediators 
from their intracellular granules (degranulation) upon challenge with antigen or allergen, 
such as pollen, in sensitized individuals82.  When mast cells degranulate, all granules 
undergo exocytosis.  This process is physiologically important for the release of 
intracellular mediators such as histamine at correct sites in tissue.  Novel imaging 
techniques using internal reflection microscopy have been used to analyze recruitment of 
granules, docking at the plasma membrane, and exocytosis83.  The well defined stages 
within the exocytotic pathway include ATP-dependent priming steps, movement of 
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vesicles to the subplasmalemmal membrane, docking at release sites, triggered membrane 
fusion, and release of granule contents. 
RBL-2H3 mast cells can be activated by aggregation of the FcεRI receptor by IgE 
bound to multivalent antigen or by methods which mobilize calcium53.  FcεRI is a 
tetrameric receptor consisting of an α chain and a membrane-tetraspanning β chain 84.  
IgE binds the α subunit of the FcεRI receptor, causing antigen cross-linking which 
prompts the phosphorylation by Lyn of tyrosine residues of the β and γ subunits of the 
receptor.  Phosphorylated sites on the γ subunit recruit the docking of spleen tyrosine 
kinase (Syk)85.  The binding of Syk to the γ subunit induces a conformational change in 
Syk and resultant autophosphorylation and liberation from the receptor.  Syk catalyzes a 
series of phosphorylation steps to activate proteins such as the linker for activation of T-
cells (LAT) and PI3K86.  PLCγ1is recruited to the membrane by LAT where it is 
phosphorylated by Syk.  PLCγ1 catalyzes the hydrolysis of phosphatidylinositol 4,5-
bisphosphate (PIP2) to inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG)87.  
IP3 initiates a biphasic increase in intracellular calcium, and DAG activates protein 
kinase C (PKC).  IP3 binds its receptor on the endoplasmic reticulum (ER), causing 
calcium to be released from internal ER stores.  Calcium depletion from ER stores 
prompts a conformational change in STIM1 to allow for interaction with calcium release 
activated calcium (CRAC) channel/Orai1 in the plasma membrane, resulting in a calcium 
influx88.  Sarco/endoplasmic calcium ATPase (SERCA) pumps permit the reuptake of 
this calcium to replenish ER stores and sustain cytosolic increase in Ca2+, the essential 
signal for mast cell activation89.  The dynamics and spatial configuration of the 
 
 
12 
 
intracellular calcium signal is shaped by the mitochondria which possess a high capacity 
for calcium buffering as well as specialized mechanisms for Ca2+ uptake and efflux90.  
Phosphorylation of protein myosin by PKC allows for cytoskeleton rearrangement 
to facilitate granule mobilization essential for degranulation.  Intracellular calcium and 
PKC activate PLD in two isoforms in RBL cells: PLD1, which is involved in granule 
translocation, and PLD2, which is involved in energy dependent step of membrane fusion 
of granules where they dock with SNARE proteins91.  These signaling processes induce 
degranulation, or the release of various mediators such as histamine.  A schematic of the 
degranulation pathway is provided in Figure 2.  
For the purposes of this study, it is important to note that these processes are 
energy (ATP) dependent83, and degranulation has been shown to be inhibited in RBL57,58 
and HMC mast cells (Weatherly, Shim, Hashmi, Kennedy, Hess and Gosse, submitted) 
previously.  
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Figure 2: Schematic of degranulation pathway in mast cells. 
Figure adapted from Rachel Kennedy and Jonathon Pelletier. 
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1.5 Uncoupling of Oxidative Phosphorylation 
Mitochondria play a crucial role in an array of biological phenomena, including 
metabolism, bioenergetics, and cancer92.  Mitochondrial uncouplers disrupt the proton 
gradient across the inner mitochondrial membrane, thus disrupting the coupling between 
electron transport and oxidative phosphorylation of adenosine diphosphate (ADP) to 
make adenosine triphosphate (ATP)93.  ATP as well as CO2 and H2O are the final 
products of the tricarboxylic acid cycle (Krebs cycle) plus oxidative phosphorylation in 
the mitochondria.  Uncoupling agents, such as 2,4-dinitrophenol (DNP), decrease the 
formation of high-energy phosphate bonds and stimulate systemic oxygen consumption 
in mitochondria94. The majority of energy-rich phosphate bonds are produced during the 
step of oxidative phosphorylation, however, in the process of glycolysis, there is a net 
production of two ATP molecules. During the final phase of cellular energy production, 
ATP synthase converts ADP to ATP with the addition of inorganic phosphate.  
Mitochondrial uncouplers allow protons to flow across the inner mitochondrial 
membrane without generating ATP.  In their uncharged states, uncouplers are able to 
dissociate a proton, and in their charged states are able to take up a proton in their pH 
range of uncoupling.  Effective uncouplers generally have a pKa above 6, and less 
effective uncouplers have pKas below 6
95.  Proton ionophores, such as DNP or TCS, are 
neutral or lipophilic when protonated.  The export of protons (H+) across the inner 
mitochondrial membrane is needed for ATP production.  Protonated uncoupling 
chemicals are lipophilic and slip through the inner mitochondrial membrane, bringing 
protons into the mitochondrial matrix, thus dissipating the electrochemical proton 
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gradient in which energy from electron transport is stored.  The collapse of the essential 
proton gradient is characteristic of mitochondrial uncouplers. 
Uncoupling the electron transport chain system from the process of oxidative 
phosphorylation can be potentially lethal.  Oxidative phosphorylation slows or halts in an 
uncoupled system, stressing the electron transport chain to work furiously in an attempt 
to regenerate ATP.  While no ATP is generated, oxygen consumption continues to 
increase.  Thus, two key tests for mitochondrial uncoupling include testing for cellular 
ATP depletion and an increase in oxygen consumption 96,97.   
 
1.5.1 Effects of Known Mitochondrial Uncouplers 
At the turn of the twentieth century, phenol based 2,4-dinitrophenol (DNP), was 
popularized as an effective weight-loss agent, and is now recognized as a mitochondrial 
uncoupler98.  Due to a high rate of adverse effects and 62 documented deaths attributed to 
DNP use, the weight loss drug was recognized as systemically toxic and was banned in 
the U.S. as a weight loss supplement.  Classic symptoms of toxicity included 
hyperthermia, tachycardia, tachypnoea, diaphoresis and eventually, death98.  The shift in 
the electrochemical gradient of protons due to mitochondrial uncouplers, as previously 
mentioned (“Uncoupling of Oxidative Phosphorylation”), results in potential energy 
dissipation as heat instead of conversion to ATP.  This process rapidly consumes calories, 
allowing for weight loss.  In the case of DNP used as a weight loss aid, this heat 
production resulted in a failure of thermoregulatory homeostasis and eventual, 
uncontrollable hyperthermia.   
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In contrast to the negative effects of DNP in humans, the 33 kDa inner membrane 
mitochondrial uncoupling protein, thermogenin, exclusive to brown adipose tissue 
(“brown fat”)  in mammals is also a proton transporter which uncouples oxidative 
phosphorylation, dissipating heat of the proton gradient in the respiratory chain99. In 
response to cold or chronic overeating, heat production, or thermogenesis, in brown fat is 
activated.  Thermogenesis of brown fat in rodents has been shown to play an integral role 
in thermoregulation and energy balance, and manipulation of this process may prove to 
be effective against obesity100. 
Two proton ionophores, CCCP and carbonyl cyanide 4-(trifluoromethoxy) 
phenylhydrazone (FCCP), are known mitochondrial uncouplers shown to modulate RBL-
2H3 function53,81,101 and to suppress degranulation.  In one study, CCCP was shown to 
depolarize the plasma membrane in glucose-containing media and to decrease 
intracellular ATP in glucose-free media93.  An evident correlation is shown between the 
effect of a decrease in ATP production and dampened degranulation in cells cultured in 
the absence of glucose. CCCP has multiple effects on RBL mast cell function.  Under 
conditions which do not deplete cellular ATP, CCCP was found to depolarize cells and 
consequentially inhibit antigen-stimulated calcium uptake81.    
  As shown in previous published work from our lab, non-cytotoxic doses of TCS 
disrupt mast cell signaling. TCS affects degranulation in response to stimulation by Ag 
and calcium ionophore.  The studies suggest that a potential TCS target lies downstream 
of calcium influx across the plasma membrane.  In this study, we will explore how a 
separate mechanism involved in cellular energy production may contribute to TCS’s 
disruption of mast cell function.  
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1.6 Previous Studies 
 As mentioned earlier, the Gosse lab has found that TCS dampens mast cell 
degranulation, the release of pre-formed mediators, which is considered an early phase 
allergic response57.  A cell-based mitochondrial ToxGlo assay from Promega was used to 
test potential mast cell mitochondrial dysfunction as a result of TCS exposure.  
Preliminary data (Figure 3; Weatherly, Shim, Hashmi, Kennedy, Hess and Gosse, 
submitted) show that TCS disrupts ATP production in RBL-2H3 cells cultured in 
glucose-free, galactose-containing media (Figure 3A), with a half maximal effective 
concentration ( EC50) of 7.5-9.6 µM (95% confidence interval), without causing 
cytotoxicity (tested up to 25 µM).The same experiments were performed with human 
HMC-1.2 cells (Figure 3C), yielding similar results: disrupted ATP production with an 
EC50 of 4.2-13.7 µM (95% confidence interval) and no cytotoxicity.  Expected results 
were seen in parallel experiments conducted using known mitochondrial uncoupler, 
CCCP (Figures 3B; 3D).  As expected, ATP depletion was not observed in experiments 
utilizing glucose, wherein cells produce sufficient ATP via glycolysis.  The reduction in 
ATP with no change in plasma membrane integrity, in two cell types, suggests that TCS 
is a mitochondrial toxicant.  
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Figure 3: Cytotoxicity and ATP production of RBL-2H3 and HMC-1.2 mast cells 
exposed to toxicant in glucose or glucose-free media. 
(A) TCS for 1 hr in the presence of BSA and (B) CCCP for 1.5 hr with no BSA.  ATP 
and cytotoxicity responses were also measured in HMC-1.2 cells in galactose media 
due to TCS (C) or CCCP (D). Dose-response curves for TCS or CCCP are shown on 
a logarithmic scale.  Error bars represent standard error of the mean of data from at 
least 3 repeat experiments.  Statistical significance was determined by one-way 
ANOVA and Tukey’spost-hoc test.  **p<0.01; ***p<0.001.  (Weatherly, Shim, 
Hashmi, Kennedy, Hess and Gosse, submitted).  
 
 
. 
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TCS-methyl, which has no ionizable proton, but instead, a methyl group in its 
place, affects neither degranulation (in stark contrast to TCS’s strong inhibition of 
degranulation57) nor ATP production (Weatherly, Shim, Hashmi, Kennedy, Hess and 
Gosse, submitted).  Thus, triclosan’s effects on mast cell function are due, at least in part, 
to its ionizable proton.  Also, 5 µM TCS inhibits thapsigargin-stimulated degranulation of 
RBL-2H3 cells:  further evidence that TCS disrupts mast cell signaling and Ca2+ influx.  
As a proton ionophore, TCS likely affects numerous cell processes which depend on 
electrochemical gradients, in diverse cell types. Also, in mast cells, mitochondria play a 
role in Ca2+ influx101,102 and ROS production, both of which are needed for cytokine 
production, and have been shown to be disrupted by other proton ionophores103. 
Depletion of ATP due to mitochondrial uncoupling leads to increased fuel 
oxidation and electron transport in an effort to regenerate the proton gradient93. Since 
TCS has been shown to inhibit ATP production in a non-cytotoxic manner, we 
hypothesize that the rate of consumption of O2, the final electron acceptor in the electron 
transport chain, will rise in the presence of TCS. Oxygen consumption rate (OCR) is a 
parameter that has been used to study mitochondrial function, since most cellular oxygen 
consumption is via mitochondria104.  In this study, we measured the OCR as well as 
examined change in membrane potential to test the aforementioned hypotheses.  If TCS is 
found to be a mitochondrial uncoupler, this mechanism could underlie TCS cytotoxicity 
in diverse mammalian cell types of many species. 
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2 Materials and Methods 
2.1 Cell Culture 
 Rat Basophilic Leukemia (RBL) cells, clone 2H3, were provided by D. Holowka 
(Cornell University, Ithaca, NY, USA).  Cell culture methods were those previously 
established in the literature105.  RBL cells were screened for mycoplasma contamination 
roughly every 6 weeks using a MycoAlert Mycoplasma detection kit (Lonza). 
2.2 Reagents and Buffers 
2.2.1 TCS media preparation 
 Triclosan (TCS) was purchased from Sigma Aldrich (“irgasan,” ≥97% by HPLC). 
A 70 µM TCS stock solution was prepared on each experimental day by dissolving TCS 
in 100 mL of cell culture water (Bio Whittaker).  Effective dissolution methods which 
avoid the use of organic solvents were used58.  A cell culture water control stock was 
prepared similarly alongside the TCS.  Concentration was determined via UV-Vis 
spectrophotometry.  Absorbance was recorded at 280 nm, and final TCS concentration 
was determined using a 1 cm path length, a 4200 M-1Lcm-1extinction coefficient of TCS, 
and the Beer-Lambert equation.  The following media components were measured and 
added at 39°C, while stirring, to both TCS and control media and thoroughly mixed: 8.3 
g/L Dulbecco’s Modified Eagle’s Medium powder without glucose, L-glutamine, phenol 
red, sodium pyruvate, and sodium bicarbonate (Sigma, D5030-10L), 10 mM D-(+)-
galactose (Sigma, G5388-100G), 3.7 g/L sodium bicarbonate (J.T. Baker, 3509-01), and 
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0.584 g/L L-glutamine (Lonza from VWR, 17-605E).  The pH was adjusted to 7.4 using 
concentrated HCl (BDH), and bovine serum albumin (BSA; Calbiochem) was added. 
 TCS stock solution was prepared as described above for Mitochondrial Membrane 
Potential (MMP) assays beginning with a 100 µM TCS stock solution. TCS was 
dissolved in Tyrodes Buffer (see 2.2.4) in place of cell culture water and no additional 
media components were added. 
2.2.2 CCCP stock preparation 
Carbonyl cyanide m-chlorophenylhydrazone (CCCP), purchased from VWR, was 
dissolved in 100% DMSO to produce a 100 mM stock solution that was stored at -20°C 
until the day of use.  Glucose-free, galactose-containing media composed of 8.3 g/L 
Dulbecco’s Modified Eagle’s Medium, 10 mM D-(+)-galactose (Sigma), 0.584 g/L L-
glutamine (Lonza), and 3.7 g/L sodium bicarbonate (VWR) was freshly prepared in 50 
mL of cell culture water on the experimental day.  CCCP stock was diluted in galactose 
media to generate a 200 µM CCCP working stock (0.2% DMSO) from which dilutions of 
0 µM, 1 µM, and 3 µM were made.  Previous control experiments have shown that the 
tested concentrations of DMSO are not cytotoxic (data not shown). 
For mitochondrial membrane potential assays, CCCP positive control is provided 
by the kit supplier as a 2 mM stock solution in DMSO. 
 
2.2.3 Phenol-red free media 
 Phenol-red free media was used to plate RBL cells 18- 20 hours prior to assaying 
oxygen consumption.  Phenol-red free minimum essential medium (MEM) without L-
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glutamine (Quality Biological) was used in order to minimize background fluorescence 
due to phenol red pH indicator.  Fetal Bovine Serum (FBS) from Atlanta Biologicals (Lot 
# F13098), stored at -20°C was thawed for four hours in a 37°C water bath prior to 
making the media.  The same lot of FBS was used throughout associated assays for 
consistency.  All media preparation was performed in a SterilGard tissue culture hood 
sterilized with 70 % ethanol.  FBS, pre-warmed to aid in filtering, was measured out 
using two 50 mL conical tubes for a total volume of 100 mL which was then added to 
400 mL of MEM.  Room temperature gentamicin sulfate antibiotic (Lonza) was added to 
500 mL of media with a sterile pipette.  For a final concentration of 2 mM,   5 mL of 200 
mM L-Glutamine (Lonza) was then added to the media.  Media was filtered into a sterile, 
glass, tissue culture media bottle that had previously been autoclaved.  A new VacuCap 
60 filter with 0.2 µM Supor Membrane (Pall Corporation) was used for vacuum filtration.  
2.2.4 Tyrodes Buffer 
 Tyrodes buffer was composed of 135 mM NaCl (EMD Millipore), 5 mM KCl (JT 
Baker), 1.8 mM CaCl2 (ACROS Organics), 1 mM MgCl2, 5.6 mM D-(+)-glucose (MP 
BIO), and 20 mM HEPES sodium salt (JT Baker).  Stock solutions of NaCl, KCl, MgCl2 
and CaCl2 were created in advance in 1M or 0.5 M concentrations, sterile filtered using a 
0.2 µM VacuCap filter and stored at 4°C.  Buffer components were dissolved in 1 L of 
ultra-pure Milli-Q water, thoroughly mixed, and sterile filtered. The pH was adjusted to 
7.4 and the buffer was stored at 4°C until the day of use. 
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2.3 Mitochondrial Membrane Potential Assays 
Mitochondrial membrane potential was assayed using a Mito-ID Membrane 
potential cytotoxicity kit for microplates (Enzo Life Sciences). This kit uses a cationic 
dual-emission dye. In normal cells, the inner mitochondrial membrane is highly polarized 
and the dye undergoes electrophoretic uptake into the negatively charged inner 
mitochondrial matrix.  The dye fluoresces orange under these normal/polarized 
conditions.  In contrast, in cells whose mitochondria have low membrane potential, e.g., 
due to mitochondrial uncoupling, the dye remains in the cytosol and fluoresces green106. 
The kit was used according the manufacturer’s instructions, using the rapid 
kinetics measurement, with the following modifications.  RBL cells were plated in a 
black-walled, clear-bottom 96-well microplate (Greiner Bio-One) at a density of 50,000 
cells per well.  Cells were incubated overnight (16-18 h) in plain RBL media in 5% CO2 
at 37°C.  Cells were plated for duplicate samples of positive and negative controls and 
four concentrations of toxicant.  
Mito-ID Dye loading solution was prepared by adding 100 μL of light sensitive 
Mito-ID MP Detection Reagent, 1 mL 10X Assay Buffer 1 and 0.2 mL of 50X Assay 
Buffer 2, supplied by the kit, into 8.7 mL deionized water.  Reagents were thoroughly 
mixed and unused aliquots of 1.3mL were wrapped in aluminum foil and stored in 
microcentrifuge tubes at -20°C until the day of use.   
On the experimental day, 1mg/mL BSA in Tyrodes Buffer was added to make 
Tyrodes-BSA buffer (BT) and placed in a 37°C water bath of previously autoclaved 
milli-Q water.  CCCP (2 mM stock) was diluted in BT to generate a 44 µM CCCP 
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working stock (2.2% DMSO), which served as the positive control.  Four TCS 
concentrations diluted in BT (0.003 µM, 15 µM, 45 µM, and 75 µM)were tested.  TCS 
dilutions were made 3X the desired final concentrations.  The prepared microplates 
containing cells were observed under a microscope for 80-100% confluence.  Spent 
media was discarded in a waste receptacle and cells were washed twice with 200 µL 
control BT.  A volume of 100 µL of BT was added into each well, followed by 100 µL of 
the prepared Mito-ID Dye Loading Solution directly into the BT. The plate was incubated 
at room temperature for 30 minutes and shielded from light.  To the respective duplicate 
wells, 100 µL of TCS dilutions and 20 µL of 44 µM CCCP (final concentration of 4 µM, 
0.2% DMSO) were added.  The bottom of the plate was wiped with a KimWipe and 
fluorescence measurements of the dye were monitored for 60 minutes via a fluorescent 
microplate reader (BioTek; Synergy).  The dye was excited at 490 nm and fluorescence 
intensity was measured at 590 nm at normal speed and a sensitivity of 40.  The plate was 
read from the bottom with a topical offset of 7 mm.  A second read was conducted with 
the same setting, but at an emission of 528/20 nm in order to calculate a ratio of orange to 
green fluorescence.  
The above procedure was followed without cells in order to perform a no-cell 
control experiment.  
2.4 Oxygen Consumption Rate Assays 
Oxygen consumption rate (OCR) was assayed using an OCR Assay Kit 
(MitoXpress-Xtra HS Method) from Cayman Chemical (Ann Arbor, Michigan).  This kit 
uses a MitoXpress-Xtra phosphorescent oxygen probe to measure the OCR in living 
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cells.  The phosphorescence of the kit’s MitoXpress probe is quenched by oxygen such 
that the emission measured is inversely proportional to the amount of oxygen present in 
the wells (i.e. an increase in emission indicates oxygen depletion)104.   
Prior to use, the MitoXpress probe was centrifuged to localize the contents at the 
bottom of the vial and then reconstituted in 1 mL of sterile, cell culture water.  The vial 
was vortexed for 30 seconds, followed by a 30 minute sonication step to ensure 
dissolution of the lyophilized reagent.  The reconstituted probe was then vortexed for 30 
seconds and centrifuged again before aliquots of 50 µL were prepared in microcentrifuge 
tubes, wrapped in parafilm and aluminum foil, and stored at -20°C until the experimental 
day. 
The OCR assay was performed in standard mode as per the manufacturer’s 
instructions with the following changes.  Cells were plated in phenol-red free media at a 
density of 50,000 cells per well in a black, clear-bottom 96-well plate.  Cells were 
incubated overnight (16-18 h) in 5% CO2 and 37°C. The following day, all equipment 
was pre-warmed so that each step in the OCR assay was performed at 37-39°C.  The 
bacterial incubator, heat blocks, water baths, hot plates for TCS dissolution, and the 
fluorescence microplate reader were pre-warmed and all micropipettes and disposables 
were warmed in a 39°C bacterial incubator.  Master mixes of the test compound (TCS or 
CCCP) were prepared with MitoXpress probe in glucose-free, galactose containing media 
(without BSA for CCCP).  All dilutions were prepared in pre-warmed conical tubes and 
microcentrifuge tubes placed in corresponding heat blocks.  Master mixes were vortexed, 
inverted, and spun down in a microcentrifuge.  Spent media in the 96-well plate was 
discarded and wells were washed once with galactose media.  The plate was placed on a 
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96-well plate heat block and a volume of 420 µL of each sample was added to 
corresponding wells.  Bubbles, which trap oxygen and may cause error in the experiment, 
were carefully popped.  Just enough sample volume was added to slightly bubble above 
the wells without resulting in overflow to allow for a flush seal when the plate was sealed 
with an oxygen impermeable aluminum plate sealer (VWR).  The plate sealer works to 
effectively trap external oxygen from entering the wells.  The plate was inserted into the 
fluorescence microplate reader set at 37°C and left to incubate for 4 minutes before the 
plate was read.  The phosphorescent probe was excited with a 360/40 nm excitation filter 
set and emission intensity was measured via a 645/15 nm emission filter.  Light emission 
was read from the bottom of the plate at normal speed with a sensitivity setting of 
90.Emission was monitored for 3 hours at 3 minute intervals.  Due to the sensitivity of 
this assay, stringent plate reader parameters were set specifically for the Greiner Bio-One 
black, clear bottom 96 well plate (Cat no. 655090; Figure #4).  
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Figure 4: Instrument Signal Optimization 
Plate reader settings determined for Greiner Bio-One black, clear bottom 96 well 
plate. Bottom Right X is the distance from the left side of the plate to the center of 
the last well on the plate (A-G from diagram). Bottom Right Y is the distance from 
the top of the plate to the center of the last well on the plate (B-H from diagram). 
All dimensions are in millimeters. Schematic adapted from Greiner Bio-One, 2011. 
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2.5 Glucose Oxidase and Antimycin A Controls 
Glucose oxidase (GO) and Antimycin A (AA; in DMSO) (obtained from the 
MitoXpress-Xtra HS Method kit from Cayman Chemical, Ann Arbor, Michigan) control 
experiments were performed according to the procedure described in 2.4 (Oxygen 
consumption rate assays).  Prior to use, GO was reconstituted in 0.2 mL of sterile, 
distilled water and stored at -20°C where it is stable for up to two months.  Antimycin A, 
an inhibitor of the mitochondrial electron transport chain, was used as a positive control.  
Glucose oxidase was used as a reference for oxygen depletion.  GO was used in place of 
cells in the GO control assay. 
2.6 Data analyses 
Data from OCR assays were analyzed by first averaging the sample replicates.  
Corresponding emission of no probe-containing samples(background)was subtracted 
from probe-containing samples in order to obtain emission due to the probe itself.  For 
example, [0 µM TCS+Probe+Cells] – [0 µM TCS+No Probe+Cells] = 0 µM TCS +Cells.  
[0 µM TCS+Probe+No Cells] – [0 µM TCS+No Probe+No Cells] = 0 µM TCS+No 
Cells.  Next, the no-cell containing controls were subtracted in order to determine the 
emission due to the depletion of oxygen by the cells.  Continuing with the previous 
example: [0 µM TCS+Cells] – [0 µM TCS+No Cells] = Final 0 µM TCS value.  This 
process was performed at each time point for every TCS concentration.  Data were 
entered into GraphPad Prism software, and slope by linear regression was determined.  
Slopes were normalized to 0 µM and graphed in a bar graph format.  Significance was 
obtained via a one-way ANOVA with Tukey’s post-hoc test. 
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MMP assays were analyzed by plotting raw fluorescence values against TCS 
concentration in GraphPad.  Significance was obtained as described for OCR assays. 
 
3 Results 
3.1 TCS Interference in Measuring Mitochondrial Membrane Potential 
In order to test effects of TCS on mitochondrial membrane potential in RBL cells, 
appropriate no-cell control experiments were conducted (see 2.3. “Mitochondrial 
Membrane Potential Assays”) to first investigate whether TCS interacts with the cationic 
Mito-ID membrane potential dye, provided by Enzo Life Sciences.  In the presence of 
energetic cells (normal/polarized conditions), highly conjugated moieties of the dual-
emission Mito-ID dye delocalize a positive charge across the mitochondrial membrane 
allowing for its electrophoretic uptake into the negatively charged matrix.  The formation 
of J-aggregates upon membrane polarization causes a shift in emission from ~530-590 
nm (green) range to ~490 nm (orange)92.  It was found that, in the absence of cells, 
increasing micromolar concentrations of TCS (0, 0.001, 5, 15, and 25 µM TCS) show 
significant increases in raw fluorescence of the Mito-ID dye.  (In contrast, 4 µM CCCP, a 
control membrane potential perturbation agent107, did not affect Mito-ID dye 
fluorescence when compared to 0 µM TCS (Figure 5)).  However, TCS + BT solution, 
when measured via UV-Vis spectrophotometry, exhibited no absorbance at 485 nm or 
590 nm, where Mito-ID dye is measured.  Minimal fluorescence was seen when TCS, 
TCS + BT, and BT-only solutions (without Mito-ID dye) were measured at 485 nm 
excitation and 590 nm emission.  No change was seen between fluorescence control 
measurements of TCS and TCS + BT samples (data not shown), suggesting TCS and/or 
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BT are not fluorescing at the specified excitation and emission settings for the Mito-ID 
dye.  Control experiments suggest that TCS is most likely interacting with the fluorescent 
dye, causing it to aggregate in the cytosol.  Based on these results, we determined that the 
Mito-ID dye cannot be used with TCS to measure mitochondrial membrane potential.  
Additional assays which measure MMP commonly utilize similar cationic, fluorescent 
probes, dependent on J-aggregate formation108, which we conclude are, likely, 
incompatible with TCS. 
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3.2 Optimization and Establishment of Oxygen Consumption Rate Assays 
 Previous work done in the Gosse laboratory has determined that non-cytotoxic 
doses of TCS inhibit ATP production in multiple cell types (Weatherly, Shim, Hashmi, 
Kennedy, Hess and Gosse, submitted).  Oxygen consumption rate (OCR) assays can be 
performed to further investigate triclosan’s effects on mitochondrial function: in 
particular, to assess its ability to uncouple oxidative phosphorylation from ATP 
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Figure 5: TCS Interference with Mito-ID Membrane Potential Dye 
Raw fluorescence values of varying micromolar concentrations of TCS treated 
with Mito-ID dye in a no-cell control assay (590 nm emission). TCS is most likely 
causing the dye to aggregate. Significance was determined via one-way ANOVA 
and Tukey’spost hoc test in GraphPad Prism software. ***p<0.001. 
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synthesis109.  Our protocol for OCR assays performed in RBL cells was based upon the 
general assay protocol provided by the manufacturer (Cayman Chemical), with various 
modifications.  Measurements were taken in standard fluorescence intensity mode, rather 
than in time-resolved mode, using a BioTek Synergy 2 Microplate reader.  Due to the 
extreme technical sensitivity of this assay, a series of parameters were tested before the 
protocol could be optimized (see Figure 6 for a summary of optimization tests).  For 
suitable measurement of MitoXpress probe, plate reader parameters first needed to be set 
specifically for the assay.  A gain setting of 90 was determined to be the most optimal.  A 
Greiner Bio-One 96 well plate (Cat # 655090) with minimal autofluorescence was chosen 
for OCR assays and specific plate dimensions (Figure 4) were programmed, along with 
the optimized plate reader settings, into Gen5 (version 2.04) plate reader software.  To 
ensure full potency of lyophilized probe provided by the manufacturer, MitoXpress probe 
was reconstituted and sonicated as described in Materials and Methods (section 2.4).  For 
maximal temperature equilibration, to avoid data artifacts, it was determined that all 
instruments, reagents, buffers and materials must be pre-warmed to ~ 37°C and kept at 
this temperature throughout the completion of the assay.  This helped to minimize a “dip” 
in initial fluorescence readings due to temperature adjustment of media components 
within individual wells of the 96 well plate.  Another step evaluated in the development 
of this protocol was the determination of optimal cell density which would provide an 
even monolayer of confluent cells and the greatest rate (slope) of oxygen consumption.  
A range of cell densities were tested and 50,000 cells per well was determined to yield 
the most optimal oxygen consumption rate based on the aerobic capacity of RBL cells 
(Figure 7).  In previous studies of TCS effects on ATP production in RBL cells, glucose-
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free, galactose-containing media was utilized to avoid ATP production via glycolysis 
(Weatherly, Shim, Hashmi, Kennedy, Hess and Gosse, submitted).  For consistency and 
data comparability, the same media conditions were established for OCR assays.  In 
control experiments, OCR measured in cells supplemented with galactose media was 
higher than in parallel assays using glucose media (data not shown).  All serum, media 
and buffer ingredients were screened for components which yielded high background 
fluorescence which may dampen fluorescence seen due to the MitoXpress probe.  It was 
determined that phenol-red pH indicator in cell media, and more significantly, the HS 
Mineral Oil overlay (provided by the manufacturer) yielded high background 
fluorescence, which obscured signal due to cellular oxygen consumption (Figure 8).  
Lonza MEM without phenol-red, without L-Glutamine and with Earle’s Balanced Salts 
(Cat # 10128-658) was incorporated in a phenol red-free media (see Materials and 
Methods, section 2.2.3) in which cells were seeded.  Various alternative oil overlays were 
tested for fluorescence and were found to be high in fluorescence at the measured 
wavelengths, so an oxygen-impermeable aluminum plate sealer (VWR) with minimal 
fluorescence was utilized as an alternative (Figure 9).  Aluminum leaching into samples 
was not of concern as the extent of leaching is significant only at high temperatures and 
low pH ranges which lie outside of our experimental parameters110.  Master mixes of the 
test compounds were prepared to eliminate systematic error due to pipetting 
inconsistencies.  Wells were filled with 420 µL total volumes, slightly more than 
suggested maximum, in order to eliminate the formation of bubbles which may trap 
external oxygen beneath the adherent plate sealer if wells were not otherwise sealed flush 
to the top.  Furthermore, to most efficiently assess OCR effects, cells were treated 
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immediately prior to measurement and equilibrated at 37°C for 4 minutes within the 
microplate reader prior to read.  Collectively, all optimization parameters tested were 
tailored to our system in order to effectively and accurately measure OCR effects in RBL 
cells.  
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Parameter Examined Experimental Test Conclusion 
Cell density to be 
plated in a black, clear 
bottom 96-well plate 
which will produce 80-
90% confluence on 
experimental day and 
greatest rate of oxygen 
consumption 
Cell densities tested: 
0.5 x 106 cells/well 
0.4 x 106 cells/well 
0.3 x 106 cells/well 
0.2 x 106 cells/well 
0.1 x 106 cells/well 
Overnight incubation at 
37°C, 5% CO2 
Cells will be plated at 0.5 x 106 
cells/well at a volume of 100 µL 
per well for overnight incubation 
(16-20 h) for optimal OCR. 
Temperature 
equilibration to 
decrease initial dip in 
OCR fluorescence 
readings 
Tested: pre-warm 
buffers, assay reagents, 
pipettes, and pipette tips 
using the following 
equipment: water baths, 
titer heat blocks, 
incubators, and 
microplate reader. 
 
Dip in fluorescence readings is 
decreased by pre-warming all 
assay components and strictly 
maintaining a consistent 
environment of 37-39°C 
throughout the duration of the 
experiment.  
Fluorescence reading 
variations between 
replicate wells 
Tested: Effectiveness of 
probe after adjusting 
reagent reconstitution 
methods 
Phosphorescent probe works 
most effectively when 
lyophilized probe is centrifuged, 
reconstituted in sterile cell culture 
water, vortexed for 30 s, 
sonicated for 30 min, vortexed 
again for 30 s, centrifuged once 
again, and stored at -20°C in 50 
µL volumes to minimize freeze-
thaw cycles and maintain potency 
of the probe.  Master mixes of 
test samples were created on 
experimental day to eliminate 
variation between wells due to 
pipetting error. 
High background 
fluorescence resulting 
in failure to detect 
increase in emission 
values upon treatment 
with probe  
Tested:  Fluorescence 
controls of all buffer 
components and contents 
of wells were performed. 
Varying volumes of 
media were tested 
beneath a fixed volume 
of HS Mineral Oil 
overlay (e.g. 100 µL oil 
to 275 µL BT; 100 µL oil 
to 170 µL BT).  
Fluorescence of HS Mineral Oil 
overlay provided by the 
manufacturer is too high (4500-
5000 RFU) to detect emission of 
phosphorescent probe at the 
prescribed settings.  Particles of 
the highly fluorescent oil may 
still be settling into media when 
volumes of media are increased 
beneath the overlay. An 
alternative must be used. 
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Alternatives to HS 
Mineral Oil overlay 
which effectively trap 
oxygen within 
individual wells, 
allowing for accurate 
signal determination 
due to probe.  
Tested: Raw fluorescence 
of various oil overlays 
and effectiveness of 
plastic and aluminum 
adherent plate sealers. 
 
All oil overlays tested have high 
RFU and plastic plate sealers 
were not effective at blocking 
oxygen.  An oxygen 
impermeable, aluminum plate 
sealer with minimal 
autofluorescence or leaching of 
aluminum was utilized.  
Plate reader parameters Tested: Gain settings of 
80, 90, and 100 for 
highest 
signal/background ratio 
in no-cell controls.  
A gain setting of 90 indicated 
highest signal/background ratio. 
Instrument parameters were 
adjusted to recognize dimensions 
specific to the Greiner Bio-One 
Clear Bottom 96-well plate.   
Use of galactose or 
glucose containing 
media 
Tested: OCR in RBL 
cells in galactose media, 
galactose-BT, glucose 
media, and glucose-BT 
Linear regression data indicate 
higher OCR in galactose 
conditions.  These media 
conditions are consistent with 
previous ATP assays associated 
with this study. 
Probe to media ratio Manufacturer 
instructions suggest 10 
µL probe to 170 µL 
media.  Ratios were 
adjusted to determine if a 
higher proportion of 
probe would enhance 
signal.  
Addition of probe to increase 
probe/media ratios does not 
enhance the signal seen due to 
MX probe.  Probe volume 
should, however, remain 
proportional to cell density.   
Data analysis 0, 5, and 10 µM TCS 
each require their own 
no-cell and no-probe 
controls. 
 
Appropriate no-cell and no-probe 
controls must be conducted per 
experimental condition to be 
subtracted during data analysis so 
that OCR seen is due to probe. 
 
Figure 6: Optimization of Oxygen Consumption Rate Assay Protocol 
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Figure 7: RBL Cell Density Optimization 
OCR of varying RBL cell densities (50,000, 40,000, 30,000, 20,000, and 10,000 
cells/well) was measured (RFUs) to determine a cell density which would yield the 
greatest OCR.  No-cell ± probe controls were also performed.  
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Figure 8: Fluorescence controls to identify source of high background 
Raw fluorescence measurements of buffers, milli-Q water, and cell culture water, 
and HS Mineral Oil overlay. 
r 
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Figure 9: Raw fluorescence of various oil overlays 
Raw fluorescence values of various oils were compared against BT in order to seek 
an alternative to the highly fluorescent HS Mineral Oil overlay.   
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3.3 TCS Effect on Cellular Oxygen Consumption 
 After optimization to our system, OCR was measured in RBL cells using a 
MitoXpress, cell-impermeable, phosphorescent probe according to the Methods described 
earlier.   Representative linear data indicate that RBL cells exposed to 10 µM TCS 
exhibit an increase in OCR when compared to 0 µM untreated control in glucose-free, 
galactose-containing media, as shown in Figure 10A.  Combined data of three individual 
experiments with two replicates each indicate a 1.17-fold ± 0.06 (SEM) increase in 
cellular OCR in RBL cells at 5 µM when compared to the untreated control and a 1.6-
fold ± 0.1 (SEM) increase at 10 µM (also compared to 0 µM TCS untreated control; 
Figure 11A).  Parallel experiments were conducted using 1 µM CCCP and a 0 µM 
untreated control, also showing an increase in OCR (Figure 10B).  A 1.5-fold ± 0.1 
(SEM) increase is seen at 1 µM CCCP when compared to the untreated control (Figure 
11B).  Our data indicate that 10 µM TCS is nearly as potent as 1 µM CCCP.  An increase 
in cellular oxygen consumption, seen during a three hour reading measurement, indicates 
that the cells remained viable throughout the assay. Upon observation, cells also appeared 
healthy following the assay.   
No-cell control experiments show a slope of zero, or no increase in emission over 
time, in the presence of probe.  Furthermore, the addition of TCS, in the absence of 
probe, did not cause an artificial increase in fluorescence over time (data not shown).  
These OCR data indicate that TCS increases cellular oxygen consumption, similar to the 
known mitochondrial uncoupler CCCP.  Taken together, TCS’s effects on disrupting 
ATP production and increasing cellular OCR further indicate that it is a mitochondrial 
uncoupler.  
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A) 
B) 
Figure 10: Representative linear data of OCR in RBL cells 
RBL cellular OCR was measured in the presence of 10 µM TCS (A) and 1 µM 
CCCP (B) and corresponding 0 µM untreated controls.  Data representative of 
individual experiments were plotted in GraphPad Prism software. 
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A) 
B) 
Figure 11: Slope of OCR effects due to toxicant exposure 
OCR was measured in glucose-free, galactose-containing media in RBL 
cells.  Effects of 5 µM and 10 µM TCS were compared to a 0 µM untreated 
control.  Effects of 1 µM CCCP, a positive control for this assay, were 
compared to 0 µM untreated control.  Values depicted represent the mean ± 
SEM of (A) three independent experiments (B) five independent 
experiments; two replicates per experiment.  Significance was determined 
via one-way ANOVA and Tukey’spost hoc test in GraphPad Prism 
software. **p<0.01 
 
 
 
 
43 
 
3.4 Validation that the Increase in OCR is not due to Toxicant Interaction 
with Phosphorescent Oxygen Probe 
 In order to validate the results of our OCR data, respiration of RBL cells was 
measured in the presence and absence of an electron transport chain inhibitor, Antimycin 
A (AA).  AA inhibits electron transport beyond complex III in the electron transport 
chain111.  In the presence of AA, RBL cells exhibited no increase in respiration.  AA 
blocks any increase of OCR by TCS in RBL cells (Figure 12). 
To further confirm that the increase in oxygen consumption is due to cellular 
depletion of oxygen and not due to interaction of toxicant with the phosphorescent probe, 
glucose oxidase was used as a reference for oxygen depletion.  In a no-cell experiment, it 
was determined that 5 and 10 µM TCS do not affect emission due to the phosphorescent 
probe in a deoxygenated environment (Figure 13A).  Parallel experiments were 
conducted with 1 µM CCCP control and a slight dampening in emission was seen (Figure 
13B).  This dampening, possibly due to toxicant interaction with the probe or with 
glucose oxidase, would, however, only lead to a slight underestimation of CCCP effects 
on OCR.  
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Figure 12: OCR effects in RBL cells in the presence of ± Antimycin A (AA) 
and ± TCS 
OCR was measured in RBL cells in the presence of electron transport chain 
inhibitor, Antimycin A under the following experimental conditions:  0 µM TCS 
+ AA and 10 µM TCS + AA with corresponding no AA-containing controls.  
Values represent the mean ± SEM of three independent experiments; two 
replicates per experiment.  Significance was determined via one-way ANOVA 
and Tukey’spost hoc test in GraphPad Prism software. ***p<0.001; *p<0.05. 
 
 
45 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A) 
B) 
Figure 13: OCR Measured in Oxygen Depleted, No-Cell Environment 
Glucose oxidase was added to master mixes containing TCS (A) or CCCP (B) and 
OCR was measured (as described in Materials and Methods) in the absence of cells; 
two replicates per experiment.  Raw Fluorescence Units (RFU) displayed are means 
± SD of two independent experiments per condition (TCS or CCCP). 
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4 Discussion 
4.1 Discussion of Mitochondrial Membrane Potential Assay 
The energy inherent in the electrochemical proton gradient built by the electron 
transport chain within the inner mitochondrial membrane drives the synthesis of ATP.  
By dissipating the proton gradient, mitochondrial uncouplers disrupt the tight coupling 
between electron transport and oxidative phosphorylation.  Pharmacologic uncoupling by 
these hydrophobic molecules, which possess dissociable protons, causes depolarization 
across the mitochondrial membrane112.  In normal cells, the inner mitochondrial 
membrane is highly polarized93.  Proton ionophores have been shown to decrease 
mitochondrial membrane potential 113.  Due to potential TCS interference with the 
cationic, dual-emission membrane potential dye provided by Enzo Life Sciences, we 
were unable to measure fluctuations in MMP due to TCS.  Characteristic of most 
mitochondrial probes is the formation of fluorescent J-aggregates within the cytosol or 
within mitochondria (described in “Results”).  Figure 1 depicts a no-cell control 
experiment where TCS treated with Mito-ID MMP dye shows a significant increase in 
fluorescence due to increasing concentrations of TCS, which, in the presence of cells, 
would have suggested false hyperpolarization.  If TCS is indeed interacting with the 
Mito-ID dye, such methods are ineffective for measuring TCS effects on MMP.  
Pendergrass et al, has examined the efficacy of such lipophilic, cationic fluorescent dyes 
which measure changes in MMP in living cells114.  Although the study reports confidence 
in the use of MMP dyes such as Chloromethyl-X-rosamine (CMXRos) and MitoTracker 
Green (MTG), they caution investigators to determine that observations gathered from 
experiments relate well to the experimental system and not to erroneous dye effects114.  
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Studying the impact of environmental chemicals on mitochondrial function is a 
means of predicting exposure related toxicity115.  Using a high throughput screening 
(qHTS) approach, Attene-Ramos et al found that in HepG2 cells, TCS decreased 
mitochondrial membrane potential115: further evidence that uncoupling effects of TCS are 
due to its ionizable proton.  In cells utilizing glycolysis for their energy needs, other 
proton ionophores have been shown to depolarize the mitochondrial and plasma 
membranes81,113, reduce calcium influx across the plasma membrane81,113, and also 
increase calcium efflux from the mitochondria113.   
In mast cells, mitochondrial membrane dysfunction, namely, collapse of 
transmembrane potential, has been shown to suppress calcium-dependent pro-
inflammatory mediator release101.The dissipation of this proton gradient and resultant 
collapse of the proton motive force prevents calcium influx by inactivating the Ca2+ 
release-activated Ca2+ (CRAC) current.  Because calcium intake and resultant mediator 
release is dependent upon membrane potential, the presence of an uncoupler can severely 
impair numerous cell processes which depend on electrochemical gradients113,116.   
Furthermore, basic Henderson-Hasselbalch calculations (along with pH values for 
the mitochondrial intermembrane space and matrix117) indicate that approximately 91% 
of TCS is protonated in the mitochondrial intermembrane space and, thus, is lipophilic 
and can enter the mitochondrial matrix.  In the higher-pH matrix, ~45% of TCS 
molecules are deprotonated, charged, hydrophilic, and trapped in the matrix, thus 
shedding protons on the matrix side, decreasing the transmembrane proton motive force 
for making ATP.  We suggest that the resultant amount of TCS getting across the inner 
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mitochondrial membrane of cells exposed to micromolar levels of TCS can have 
substantial effects on uncoupling and mitochondrial dysfunction due to TCS. 
In rat thymocytes, 3 μM TCS was found to cause effects on polarization of the 
plasma membrane of intact membranes of living cells 118.  Bis-(1,3-dibutylbarbituric acid) 
trimethineoxonol (di-BA-C4) fluorescent dye was used to examine TCS effects.  In order 
to further examine the basis of TCS immunotoxicity, future experiments in the Gosse lab 
may examine TCS effects on plasma membrane potential in mast cells. TCS may be 
affecting other cellular functions which are dependent on electrochemical gradients in 
numerous cell types.  Taken together, these mechanisms of action could help explain 
TCS effects on inhibition of degranulation in mast cells.   
 
4.2 Discussion of Oxygen Consumption Rate Assays 
 Under glucose-free, galactose-fed conditions which restrict mast cells to oxidative 
phosphorylation93,119, it was previously found that TCS inhibits ATP production in RBL-
2H3 and HMC-1.2 mast cell lines (Figure 3; Weatherly, Shim, Hashmi, Kennedy, Hess 
and Gosse, submitted).  In this study, our findings show that TCS increases oxygen 
consumption rate (OCR) in RBL mast cells (Figure 10A).  Our optimized protocol for 
measuring OCR is fine-tuned for use in a standard fluorescence microplate reader, as 
opposed to measurement by Extracellular Flux (XF) technology (Seahorse Bioscience) 
specific for OCR or extracellular acidification rate measurements120. In our system, OCR 
was shown to significantly increase with 10 µM TCS, corresponding well within the EC50 
range determined for ATP depletion by TCS (Weatherly, Shim, Hashmi, Kennedy, Hess 
and Gosse, submitted).  The micromolar concentrations used in these experiments are 
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one-thousand times lower than the concentrations found commonly in TCS-containing 
personal care products 3,4.  It is interesting to note that 10 µM TCS exhibited similar 
effects on RBL mast cell OCR as 1 µM CCCP, noted as a canonical and potent uncoupler 
of oxidative phosphorylation.  We confirmed that these effects are due to cellular 
depletion of oxygen and not due to toxicant interaction with the phosphorescent probe 
(Figure 12 and 13).  
 Previous studies in the Gosse lab have found TCS to dampen degranulation in 
RBL cells in both glucose- and galactose-containing media.  Additionally, it has been 
shown that TCS dampens degranulation in human mast cells and by stimulation methods 
that bypass FcRI in RBL cells.  In addition to previously shown TCS depletion of ATP 
production at non-cytotoxic doses, a concomitant increase in cellular oxygen 
consumption supports the hypothesis that TCS is a mitochondrial uncoupler.  
 Uncouplers have been shown to have antioxidant effects as a result of their 
reduced proton motive force (PMF) and due to the shortened occupancy of time of single 
electrons within the electron carriers of the electron transport chain121.  Pharmacologic 
and genetic uncouplers have also been shown to have favorable effects on various 
disorders linked to oxidative stress122,123, including heart failure124, insulin 
resistance125,126, ischemic-reperfusion injury112, Parkinson’s disease127, and also diseases 
such as obesity which may benefit from an increase in energy expenditure128.  The 
varying usages of mitochondrial uncouplers implicate that TCS has potential aside from 
being an antimicrobial agent.  However, due to widespread exposure to TCS via common 
household and personal care products, it is important to consider the adverse effects of its 
uncoupling property98.  
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